BlackRock Fund Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
TSW
BTW
BIT
AAM
BlackRock Fund Advisors's ANIK Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Anika Therapeutics (ANIK) stake by 13% in Q4 2016, buying an estimated $6.34M and bringing the position to 1,173,660 shares worth $57.5M. The position accounts for 0.01% of the portfolio, ranked #1590.
BlackRock Fund Advisors first reported a position in ANIK in Q2 2013 and has held it in 15 quarters since. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.
- BlackRock Fund Advisors held 1,173,660 shares of Anika Therapeutics worth $57.5M as of Q4 2016.
- BlackRock Fund Advisors bought 137,064 Anika Therapeutics shares in Q4 2016, an estimated $6.34M.
- Anika Therapeutics made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1590 holding.
- BlackRock Fund Advisors first reported a position in Anika Therapeutics in Q2 2013 and has held it in 15 quarters since.
- 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.